Mumbai-based brain health startup Ivory secures $1 million in a seed funding round led by key investors including Draper Associates, SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI.
Key Highlights
- Brain health startup Ivory raises $1 million to expand technology and cognitive care solutions.
- Ivory aims to improve early detection and preventive brain health through scalable digital healthcare solutions.
The funding comes after the startup’s earlier appearances on Shark Tank India and follows previous capital raises, including $1 million in April 2025 led by IIM-A Ventures and Capital A, along with an additional $500,000 raised in February 2024.
Ivory plans to use the fresh capital to enhance its technology infrastructure, expand clinical capabilities, and strengthen its product offerings. The focus will be on building scalable, evidence-based solutions for cognitive health and early detection.
Founded in early 2023 by Issac John and Rahul Krishnan, Ivory is a brain health platform focused on proactive cognitive care and early detection of neurological issues.
The company leverages neuroscience, neuropsychology, and data-driven insights to offer clinical-grade cognitive assessments through its mobile app. Users can monitor and improve their cognitive health with personalised solutions backed by a multidisciplinary clinical team.
Also Read: Poonawalla Fincorp Bags Rs 2,500 Cr via QIP to Boost Lending Growth
Ivory is working to address a critical gap in India’s healthcare system by making cognitive screening more accessible and integrated into routine preventive care.
The startup recently partnered with Metropolis Healthcare to launch the TruHealth Mind & Body package, combining pathology diagnostics with neuroscience-based cognitive assessments.
Ivory operates in a growing digital health segment and competes with global players such as Cogstate, Altoida, Pearson, BrainCheck, and Linus Health. It also competes with traditional cognitive assessment tools like MoCA, MMSE, and ACE-III.
